These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3776831)

  • 1. Third party payment policies: design & impact.
    Schondelmeyer SW
    Am Pharm; 1986 Aug; NS26(8):41-5, 48-56, 63-8. PubMed ID: 3776831
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimating a reasonable reimbursement for community pharmacies in third-party programs.
    Carroll NV
    Manag Care Interface; 1999 Feb; 12(2):73-6, 79-80. PubMed ID: 10346189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profitability, third-party reimbursement, and access to community pharmacies.
    Carroll NV; Miederhoff PA; Waters LW
    Clin Ther; 1996; 18(4):703-15; discussion 702. PubMed ID: 8879898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case study using descriptive analysis to estimate hidden costs in processing third party prescriptions.
    Herrier RN; Spencer JR; Davis CD
    J Am Pharm Assoc (Wash); 2000; 40(5):658-65. PubMed ID: 11029847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement.
    Kreling DH; Kirk KW
    Med Care; 1986 Jul; 24(7):590-600. PubMed ID: 3523065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a change in third party reimbursement rate on prescription gross margin.
    Ganther JM; Kreling DH
    J Am Pharm Assoc (Wash); 1999; 39(3):346-52. PubMed ID: 10363461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing changes in third-party gross margin for a single community pharmacy.
    Urick BY; Urmie JM; Doucette WR; McDonough RP
    J Am Pharm Assoc (2003); 2014; 54(1):27-34. PubMed ID: 24362541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Savings from Canadian Internet pharmacies are limited.
    Rothberg M
    Ann Intern Med; 2006 Feb; 144(3):224; author reply 224-5. PubMed ID: 16461977
    [No Abstract]   [Full Text] [Related]  

  • 11. Who cares what it costs to dispense a Medicaid prescription?
    Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
    Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mail order pharmacy--savings or added cost?
    Kaye T
    Manag Care; 2003 Jun; 12(6):33-5. PubMed ID: 12854258
    [No Abstract]   [Full Text] [Related]  

  • 13. Dispensing in general practice. Overhaul system of reimbursement.
    McCormack T
    BMJ; 1993 Jun; 306(6894):1748. PubMed ID: 8343635
    [No Abstract]   [Full Text] [Related]  

  • 14. The market for retail pharmacies: a duopoly model.
    Rossiter LF
    Adv Health Econ Health Serv Res; 1982; 3():171-89. PubMed ID: 10257771
    [No Abstract]   [Full Text] [Related]  

  • 15. State and federal government mandates are changing the face of pharmacy management.
    Giaquinta D
    Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
    [No Abstract]   [Full Text] [Related]  

  • 16. Are online pharmacies good for your patients--and for you?
    Lowes R
    Med Econ; 2000 Jun; 77(11):77-80, 84-6. PubMed ID: 11010267
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors influencing pharmacists' participation in third-party programmes.
    Szeinbach SL
    J Clin Pharm Ther; 1990 Aug; 15(4):241-5. PubMed ID: 2229204
    [No Abstract]   [Full Text] [Related]  

  • 18. Third party prescription programs: cost containment issues and strategies.
    Richards JW
    Am Pharm; 1985 Jul; NS25(7):28-35. PubMed ID: 4036802
    [No Abstract]   [Full Text] [Related]  

  • 19. Is Rx couponing a viable direct-marketing technique?
    Spaulding CD; Josephs JW
    Am Pharm; 1992 Jan; NS32(1):67-71. PubMed ID: 1570791
    [No Abstract]   [Full Text] [Related]  

  • 20. Summaries for patients. Price comparison for brand name drugs purchased through the Internet from Canada- and U.S.-based pharmacies.
    Ann Intern Med; 2005 Sep; 143(6):I24. PubMed ID: 16172435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.